MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Testing the body vs brain-first hypothesis in early PD: a cross-sectional study

    A. Querejeta-Coma, H. Canfield, L. Yupanqui-Guerra, L. Santos-Sánchez-de-Las-Matas, M. Sánchez-Boyero, E. Escario, M. Pintor-Zamora, CM. Ordás-Bandera (Móstoles, Spain)

  • Thalamic Hub Dysregulation in FCMTE1: Multimodal MRI and Gene-Imaging Evidence

    JX. Li, HT. Wang, B. Wang, W. Luo (Hangzhou, China)

  • THD (Tyrosine Hydroxylase Deficiency) in a 39-Year-Old Woman with Early-Onset Dystonia

    T. Le (Dallas, USA)

  • The “Sequestration” hypothesis: Longitudinal systemic priming and CNS infiltration of Neutrophil Extracellular Traps in Parkinson’s Disease

    HD. Nguyen, S. Lee, H. Ma, YJ. Kim, HJ. Kim, YE. Kim (Anyang, Republic of Korea)

  • The “Guarda” (Tower) Drawing Test: A Novel Bedside Tool to Quantify Bradykinesia in Parkinson’s Disease

    S. Celi Aguilar, F. Ramos, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (Buenos Aires, Argentina)

  • The 360° Turn Test as a Single and Dual Task in people with Parkinson’s disease and cognitively unimpaired controls

    M. Lindh-Rengifo, S. Fors, S. Palmqvist, E. Stomrud, N. Mattsson-Carlgren, M. Nilsson (Malmö, Sweden)

  • The Allosteric Activator of Lysosomal Glucocerebrosidase VQ-101 Demonstrates Robust Evidence of Target and Pathway Engagement in People with Parkinson’s Disease: Results from a 6-Month Open-Label Extension Study

    M. Facheris, J. Valk, I. Koopmans, K. Hunt, M. Hagey, O. Siddiqui, P. Kremer, J. Sullivan, D. Ysselstein (Chicago, USA)

  • The Alternating Finger Tapping Test Poorly Predicts Real-World Daily Activity Performance in Parkinson’s Disease

    P. Kaewsom, K. Horaruengdecha, P. Panyakaew (Bangkok, Thailand)

  • The Anxiolytic Effect of Cannabidiol and Tetrahydrocannabinol in a Reserpine Model of Parkinson’s Disease in Mice

    H. Tanko, T. Muhammad, A-S. Isa (Zaria, Nigeria)

  • The Association between Antiepileptic Drug Use, Epilepsy and the Risk of Parkinson’s Disease: A Systematic Review and Meta-analysis

    RG. Mohamed, O. Yousef (Mansoura, Egypt)

  • « Previous Page
  • 1
  • …
  • 186
  • 187
  • 188
  • 189
  • 190
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley